dMed Biopharmaceutical logo

dMed Biopharmaceutical

dMed Biopharmaceutical is a clinical Research Organization founded in 2016 by Lingshi Tan.

5

Funding Rounds

$214.0m

Money raised

Overview

dMed Biopharmaceutical is a clinical Research Organization founded in 2016 by Lingshi Tan.

Funding

Funding series

Funding Series Analysis

The company dMed Biopharmaceutical has raised a total of $200m in funding over 5 rounds.

Key Insights:

  • dMed Biopharmaceutical , July 2021: $50m
  • dMed Biopharmaceutical Series C round, December 2020: $100m
  • dMed Biopharmaceutical Series B round, October 2019: $50m
  • dMed Biopharmaceutical Series A round, December 1, 2016: $8m
  • dMed Biopharmaceutical Series B round, July 1, 2018: $6m
dMed Biopharmaceutical logo
dMed Biopharmaceutical , July 2021 $50m
dMed Biopharmaceutical logo
dMed Biopharmaceutical Series C round, December 2020 $100m
dMed Biopharmaceutical logo
dMed Biopharmaceutical Series B round, October 2019 $50m
dMed Biopharmaceutical logo
dMed Biopharmaceutical Series A round, December 1, 2016 $8m
dMed Biopharmaceutical logo
dMed Biopharmaceutical Series B round, July 1, 2018 $6m

Industries

dMed Biopharmaceutical is active in the following industries: